![Christiane Verhaegen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Christiane Verhaegen
Plus aucun poste en cours
Profil
Christiane Verhaegen worked as an Auditor at KPMG LLP, a Principal at ING Real Estate Development, and a Principal at Ernst & Young Belgium.
She also served as the Chief Executive & Financial Officer at Unibioscreen SA from 2009 to 2011.
Verhaegen holds a graduate degree and an MBA from the University of Antwerp.
Anciens postes connus de Christiane Verhaegen
Sociétés | Poste | Fin |
---|---|---|
Unibioscreen SA
![]() Unibioscreen SA Pharmaceuticals: MajorHealth Technology Unibioscreen is a privately held specialist oncology discovery & development company. Founded in 1999 and based in Brussels, Belgium. Unibioscreen has successfully discovered, patented and developed 2 novel, first-in-class anti-cancer drug candidates (chemotherapeutics) now in clinical phase I in cancer patients and has also a discovery pipeline. | Directeur Financier/CFO | 10/05/2011 |
ING Real Estate Development
![]() ING Real Estate Development Real Estate DevelopmentFinance Part of ING Groep NV, ING Real Estate Development is a Dutch company that provides real estate services. The company is based in The Hague, Netherlands. | Corporate Officer/Principal | - |
Ernst & Young Belgium
![]() Ernst & Young Belgium Miscellaneous Commercial ServicesCommercial Services Ernst & Young Belgium provides accounting services. Its services include assurance, tax, advisory, transactions and strategic growth. The company is headquartered in Machelen, Belgium. | Corporate Officer/Principal | - |
KPMG LLP
![]() KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Comptroller/Controller/Auditor | - |
Formation de Christiane Verhaegen
University of Antwerp | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 4 |
---|---|
KPMG LLP
![]() KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Commercial Services |
ING Real Estate Development
![]() ING Real Estate Development Real Estate DevelopmentFinance Part of ING Groep NV, ING Real Estate Development is a Dutch company that provides real estate services. The company is based in The Hague, Netherlands. | Finance |
Ernst & Young Belgium
![]() Ernst & Young Belgium Miscellaneous Commercial ServicesCommercial Services Ernst & Young Belgium provides accounting services. Its services include assurance, tax, advisory, transactions and strategic growth. The company is headquartered in Machelen, Belgium. | Commercial Services |
Unibioscreen SA
![]() Unibioscreen SA Pharmaceuticals: MajorHealth Technology Unibioscreen is a privately held specialist oncology discovery & development company. Founded in 1999 and based in Brussels, Belgium. Unibioscreen has successfully discovered, patented and developed 2 novel, first-in-class anti-cancer drug candidates (chemotherapeutics) now in clinical phase I in cancer patients and has also a discovery pipeline. | Health Technology |